Tags

Type your tag names separated by a space and hit enter

Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
Transpl Infect Dis. 2020 08; 22(4):e13326.TI

Authors+Show Affiliations

Tarrant Nephrology Associates/Premier Physicians Group Health, Fort Worth, Texas, USA. Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.Tarrant Nephrology Associates/Premier Physicians Group Health, Fort Worth, Texas, USA. Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.Infectious Disease Doctors, PA, Fort Worth, Texas, USA.Lung & Sleep Center of North Texas, Fort Worth, Texas, USA.Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.

Pub Type(s)

Case Reports
Letter

Language

eng

PubMed ID

32406985

Citation

Allam, Sridhar R., et al. "Interleukin-6 Receptor Antagonist Therapy to Treat SARS-CoV-2 Driven Inflammatory Syndrome in a Kidney Transplant Recipient." Transplant Infectious Disease : an Official Journal of the Transplantation Society, vol. 22, no. 4, 2020, pp. e13326.
Allam SR, Dao A, Madhrira MM, et al. Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient. Transpl Infect Dis. 2020;22(4):e13326.
Allam, S. R., Dao, A., Madhrira, M. M., Antiporta, P. B., Nair, R. R., Guiteau, J. J., & Reyad, A. I. (2020). Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient. Transplant Infectious Disease : an Official Journal of the Transplantation Society, 22(4), e13326. https://doi.org/10.1111/tid.13326
Allam SR, et al. Interleukin-6 Receptor Antagonist Therapy to Treat SARS-CoV-2 Driven Inflammatory Syndrome in a Kidney Transplant Recipient. Transpl Infect Dis. 2020;22(4):e13326. PubMed PMID: 32406985.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient. AU - Allam,Sridhar R, AU - Dao,Ann, AU - Madhrira,Machaiah M, AU - Antiporta,Philip B, AU - Nair,Ranjit R, AU - Guiteau,Jacfranz J, AU - Reyad,Ashraf I, Y1 - 2020/06/05/ PY - 2020/05/01/received PY - 2020/05/02/revised PY - 2020/05/06/accepted PY - 2020/5/15/pubmed PY - 2020/8/28/medline PY - 2020/5/15/entrez KW - COVID-19 KW - SARS-CoV-2 KW - kidney transplant KW - tocilizumab SP - e13326 EP - e13326 JF - Transplant infectious disease : an official journal of the Transplantation Society JO - Transpl Infect Dis VL - 22 IS - 4 SN - 1399-3062 UR - https://www.unboundmedicine.com/medline/citation/32406985/Interleukin_6_receptor_antagonist_therapy_to_treat_SARS_CoV_2_driven_inflammatory_syndrome_in_a_kidney_transplant_recipient_ L2 - https://doi.org/10.1111/tid.13326 DB - PRIME DP - Unbound Medicine ER -